Insider Trading & Executive Data
Start Free Trial
118 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
The Clorox Company is a multinational consumer and professional products manufacturer with FY25 net sales of $7.1 billion and roughly 7,600 employees, selling leading brands (Clorox, Glad, Burt’s Bees, Brita, Kingsford, Hidden Valley, Fresh Step, etc.) across ~100 markets. More than 80% of sales are from No. 1 or No. 2 category positions and FY25 sales mix was concentrated in cleaning products (44%), bags & wraps (15%), food (12%) and cat litter (10%). Operations are organized into Health & Wellness, Household, Lifestyle and International segments and the company is executing an “IGNITE” strategy that emphasizes innovation, portfolio management and a large ERP/cloud transformation ($570–$580M incremental investment). Key operational risks include customer concentration (Walmart ≈27% of sales; top five customers ≈50%), commodity and transportation cost volatility, some single-source inputs, seasonality (grilling products peak Mar–Sep), and active portfolio changes including recent divestitures and the wind‑down of the Glad venture.
Given Clorox’s mix of established brands and a multi‑year transformation program, executive pay is likely tied to both short‑term financial performance (net sales, adjusted operating income or EBITDA, margin recovery and working capital metrics) and longer‑term value creation (adjusted EPS, ROIC, free cash flow and total shareholder return). The substantial ERP/cloud investment and ongoing portfolio shifts create a case for retention and performance‑vesting equity (PSUs/RSUs) to align leaders on multi‑year delivery of productivity savings, digital commerce growth and successful integration/divestiture execution. Sustainability and safety metrics (e.g., RIR 0.66) and ESG targets are also plausible modifiers to incentive plans given corporate emphasis on workforce safety and sustainability. Dividend policy (≈$602M paid in FY25) and capital allocation discipline mean executives will be evaluated on cash generation and dividend/share‑repurchase affordability as well as margin resilience against commodity and retailer concentration pressures.
Insiders at Clorox are likely subject to the usual Section 16 reporting, short‑swing profit rules, blackout windows around earnings and structured trading plans (Rule 10b5‑1) given the company’s public profile and material operational items. Material nonpublic events that can trigger heightened insider activity or trading restrictions include major retailer negotiations or order patterns (Walmart concentration and retailer ordering cycles), ERP implementation milestones and timing effects, large supply‑chain disruptions or product safety/recall events, and discrete M&A/divestiture or wind‑down announcements (e.g., Glad venture). Seasonality in grilling products and concentrated customer exposures can create predictable windows of information asymmetry (e.g., pre‑season inventory orders), so watch for insider filings clustered around those operational inflection points; investors should also monitor for retention‑related equity exercises or sales tied to multi‑year award vesting.